In accordance with the results of our KEGG analysis, Yan et al. recently found that in the IL-17 pathway, the deletion of the IL-17 receptor decreases the expression level of A20, which activates the JNK/c-JUN pathway and promotes tumor invasion, growth, and metastasis in patients with CRC [34]. The gene discussed is JUN; the disease is colorectal carcinoma.